MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 148 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $6,894,457 | +81.4% | 24,609 | +72.9% | 0.00% | +100.0% |
Q1 2024 | $3,801,316 | +15.4% | 14,235 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $3,293,695 | +42.5% | 14,235 | -10.1% | 0.00% | 0.0% |
Q3 2023 | $2,311,230 | -38.3% | 15,826 | +2.3% | 0.00% | -50.0% |
Q2 2023 | $3,748,246 | 0.0% | 15,472 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $3,748,246 | -99.7% | 15,472 | -7.0% | 0.00% | +100.0% |
Q3 2022 | $1,081,044,000 | -9.2% | 16,634 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $1,190,663,000 | -2.4% | 16,634 | +33.8% | 0.00% | 0.0% |
Q1 2022 | $1,219,631,000 | +15.8% | 12,430 | 0.0% | 0.00% | – |
Q4 2021 | $1,053,317,000 | +6.2% | 12,430 | 0.0% | 0.00% | – |
Q3 2021 | $991,789,000 | -18.1% | 12,430 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $1,210,807,000 | -12.4% | 12,430 | +5.1% | 0.00% | 0.0% |
Q1 2021 | $1,382,936,000 | +28.2% | 11,823 | +21.9% | 0.00% | 0.0% |
Q4 2020 | $1,078,460,000 | -3.2% | 9,701 | +3.4% | 0.00% | 0.0% |
Q3 2020 | $1,114,162,000 | +14.2% | 9,384 | +8.9% | 0.00% | 0.0% |
Q2 2020 | $975,650,000 | +306.9% | 8,615 | +139.8% | 0.00% | – |
Q1 2020 | $239,802,000 | -62.6% | 3,592 | -48.9% | 0.00% | – |
Q4 2019 | $641,050,000 | +101.4% | 7,036 | +90.6% | 0.00% | – |
Q3 2019 | $318,324,000 | -1.3% | 3,692 | +20.0% | 0.00% | – |
Q2 2019 | $322,396,000 | -16.3% | 3,076 | 0.0% | 0.00% | – |
Q1 2019 | $385,300,000 | +22.1% | 3,076 | +9.9% | 0.00% | – |
Q4 2018 | $315,616,000 | -62.9% | 2,800 | -29.5% | 0.00% | -100.0% |
Q3 2018 | $850,738,000 | -34.5% | 3,973 | -14.5% | 0.00% | 0.0% |
Q2 2018 | $1,299,440,000 | – | 4,646 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |